OT-551 is a NF-κB inhibitor potentially for the treatment of cataracts and age-related macular degeneration. References: Wong WT, Kam W, Cunningham D, Harrington M, Hammel K, Meyerle CB, Cukras C, Chew EY, Sadda SR, Ferris FL. Treatment of geographic atrophy by the topical administration of OT-55 results of a phase II clinical trial. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6131-9. doi: 10.1167/iovs.10-5637. PubMed PMID: 20574018; PubMed Central PMCID: PMC3055748.
纯度:≥98%
CAS:627085-11-4